marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Apellis Pharmaceuticals Cash Flow 2011-2025 | APLS
Annual Cash Flow Apellis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-595 M | -514 M | -563 M | -160 M | -211 M | -131 M | -46.6 M | -26 M | - | - | - | - | - |
Depreciation & Amortization |
1.78 M | 1.55 M | 1.38 M | 637 K | 240 K | - | - | - | - | - | - | - | - |
Accounts Payables |
37.5 M | 37.3 M | 16.9 M | 8.48 M | 8.36 M | 10.3 M | 3.66 M | - | - | - | - | - | - |
Accounts Receivables |
206 M | 7.73 M | 10.1 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
146 M | 85.7 M | 16.3 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Apellis Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -133 M | - | - | - | -178 M | - | -373 M | -219 M | -112 M | - | -451 M | -282 M | -153 M | - | -302 M | -203 M | -108 M | - | -129 M | -75.5 M | -35.6 M | - | -86.8 M | -53.6 M | -22.9 M | - | -31.1 M | -19.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 444 K | - | - | - | 421 K | - | 1.16 M | 763 K | 377 K | - | 1.01 M | 724 K | 282 K | - | 370 K | 180 K | 85 K | - | 153 K | 87 K | 41 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
42.7 M | 38.3 M | 26.8 M | 37.5 M | 18.2 M | 27.5 M | 31.5 M | 37.3 M | 14.1 M | 16.2 M | 12.3 M | 16.9 M | 4.98 M | 5.34 M | 4.16 M | 8.48 M | 8.48 M | 8.48 M | 8.48 M | 8.36 M | 8.36 M | 8.36 M | 8.36 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 3.66 M | 3.66 M | 3.66 M | 3.66 M | 2.55 M | 2.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
279 M | 304 M | 268 M | 206 M | 169 M | 111 M | 31.5 M | 7.73 M | 8.09 M | 7.52 M | 6.33 M | 10.1 M | 3.52 M | 719 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
121 M | 153 M | 161 M | 146 M | 98.5 M | 103 M | 85.5 M | 85.7 M | 59.8 M | 48.5 M | 32.8 M | 16.3 M | 1.68 M | 3.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency